Restarting Therapeutic Unfractionated Heparin After 7-Hour Interruption
Check an aPTT before restarting the heparin infusion at 2 PM, then resume at the previous maintenance rate without a bolus if the aPTT is subtherapeutic or low-therapeutic. Given the 7-hour gap since 6:45 AM, the anticoagulant effect has likely dissipated, but confirming this with an aPTT prevents inadvertent over-anticoagulation.
Rationale Based on Heparin Pharmacokinetics
Unfractionated heparin has a dose-dependent elimination half-life of approximately 60–120 minutes, with therapeutic doses cleared through both rapid saturable and slower renal mechanisms 1. After 7 hours off the infusion (approximately 3.5–7 half-lives), the anticoagulant effect should be minimal to absent in most patients 1.
- UFH is typically stopped 4–6 hours before procedures to eliminate residual anticoagulant effect 2
- This timing guidance confirms that by 7 hours, anticoagulation is expected to have resolved in the majority of patients 2
Recommended Restart Protocol
Step 1: Obtain aPTT at 2 PM
Measure the aPTT before making any dosing decisions 1, 3. This single test determines your next action and prevents both under- and over-anticoagulation.
Step 2: Resume Based on aPTT Result
If aPTT is subtherapeutic (typically <45–50 seconds or <1.5× control):
- Restart the infusion at the previous maintenance rate that was running at 6:45 AM 1
- Do not give a bolus unless the clinical situation has changed (new thrombotic event, worsening symptoms) 4
- Recheck aPTT in 6 hours to confirm therapeutic range 1, 3
If aPTT is still therapeutic or supratherapeutic (>70 seconds or >2.0× control):
- Hold the infusion and recheck aPTT in 2–4 hours 1
- Resume at a reduced rate once aPTT approaches therapeutic range 1
If aPTT is low-therapeutic (45–60 seconds):
- Resume at the previous maintenance rate without bolus 1
- Consider a small rate increase (1–2 U/kg/h) if the patient was consistently at the lower end of therapeutic range before the hold 1
Why Not Give a Bolus?
Bolus dosing is reserved for treatment initiation or documented loss of therapeutic anticoagulation with clinical deterioration 5, 6, 7, 8. In your scenario:
- The patient was already therapeutically anticoagulated before the hold 1
- There is no indication of new thrombotic events during the 7-hour gap
- Giving an 80 U/kg bolus (standard initial dosing) risks overshooting the therapeutic range and causing bleeding 6, 7, 8
- The FDA label emphasizes adjusting doses based on coagulation tests and avoiding unnecessary boluses 4
Monitoring After Restart
Check aPTT 6 hours after restarting the infusion 1, 3. This timing allows:
- Assessment of steady-state anticoagulation 1
- Dose adjustment if needed per weight-based nomogram 1
- Detection of heparin resistance or unexpected responses 4
Continue daily monitoring of:
- Platelet count (risk of HIT, especially days 5–14 of therapy) 4
- Hemoglobin/hematocrit (occult bleeding) 4
- Clinical signs of bleeding or thrombosis 4
Common Pitfalls to Avoid
Do not restart empirically without checking aPTT 4. Patient factors (renal function, age >60, concurrent medications, inflammatory states) significantly affect heparin clearance and response 1, 3. A 7-hour gap may leave residual anticoagulation in elderly patients or those with renal impairment 1.
Do not use the same approach for LMWH 2. Low molecular weight heparins have longer half-lives (3–5 hours) and different restart protocols 2.
Avoid assuming the previous dose was optimal 1. If the patient had multiple aPTT values outside therapeutic range before the hold, this is an opportunity to reassess the dosing strategy 1.